Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery

Arslan, N; Ilgan, S; Yuksel, D; Serdengecti, M; Bulakbasi, N; Ugur, ÖMER; Ozguven, MA

doi:10.1097/00003072-200108000-00004

Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery

Arslan N., Ilgan S., Yuksel D., Serdengecti M., Bulakbasi N., Ugur Ö., ...Daha Fazla

CLINICAL NUCLEAR MEDICINE, cilt.26, sa.8, ss.683-688, 2001 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 8
Basım Tarihi: 2001
Doi Numarası: 10.1097/00003072-200108000-00004
Dergi Adı: CLINICAL NUCLEAR MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.683-688
Anahtar Kelimeler: computed tomography, In-111 octreotide, magnetic resonance imaging, medullary cancer of thyroid, Tc-99m (V) DMSA, ultrasonography, SOMATOSTATIN RECEPTORS, CARCINOMA, DIAGNOSIS, CANCER, LOCALIZATION, EXPRESSION
Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose: In this retrospective study, the authors evaluated the utility of In-111 octreotide (OctreoScan) and Tc-99m (V) DMSA scintigraphy for the localization of recurrent metastatic tumor foci in patients with medullary thyroid cancer (MTC) and compared the findings with those of conventional radiologic imaging methods.